Key facts
- Everyman (Practice Management (Healthcare))’s last known valuation is $8.5M (May 2025).
- It has raised $2.1M; the latest was Early Stage VC ($1.0M) in May 2025.
- Notable investors include Kinled Holding, Calm/Storm Ventures, Ertan Wittwer, Felix Bertram, Fiona Pathiraja — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Everyman (Practice Management (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Everyman (Practice Management (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Everyman (Practice Management (Healthcare))
Developer of digital, drug, and non-drug therapies for men's health designed to provide comprehensive and science-backed solutions for men of all ages. The company's platform connects users to a Swiss medical specialist in just a few minutes for a personal diagnosis and, if necessary, a prescription, enabling men to receive convenient and effective care for a wide range of men's health issues.
- Sector
- Healthcare
- HQ
- Bern, Switzerland
- Founded
- 2023
- Employees
- 9
- Website
- everyman.health/
- Ownership
- Privately Held (backing)
Everyman (Practice Management (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Everyman (Practice Management (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Everyman (Practice Management (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.